Irvine, CA, United States of America

Abel Jimenez

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Abel Jimenez

Introduction

Abel Jimenez is a notable inventor based in Irvine, CA, who has made significant strides in the field of healthcare technology. His work focuses on developing systems that leverage artificial intelligence to improve patient care, particularly for those experiencing withdrawal symptoms.

Latest Patents

Jimenez holds a patent for an "Integrated artificial intelligence based system for monitoring and remediating withdrawal symptoms." This innovative system is designed to identify Neonatal Abstinence Syndrome (NAS) in infants and monitor withdrawal symptoms in adult patients. The technology utilizes biosensor and behavioral information collected from wearable devices, high precision cameras, and multi-pitch microphones. By analyzing this data, the system can make informed recommendations and take appropriate actions to deliver treatment when necessary.

Career Highlights

Throughout his career, Jimenez has demonstrated a commitment to advancing medical technology. His patent reflects his dedication to addressing critical health issues and improving the quality of care for vulnerable populations, such as infants and adults undergoing withdrawal.

Collaborations

Jimenez collaborates with talented professionals in his field, including Shiva Sharareh and Ariel Garcia. Their combined expertise contributes to the development and refinement of innovative healthcare solutions.

Conclusion

Abel Jimenez's contributions to healthcare technology through his patented innovations highlight the potential of artificial intelligence in improving patient outcomes. His work exemplifies the intersection of technology and medicine, paving the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…